Skip to main content
Clinical Trials/TCTR20190422003
TCTR20190422003
Completed
Phase 2

sing A Soft Robot to Assist Hand Function in Stroke Patients

THE 90TH Anniversary of Chulalongkorn University Scholarship0 sites20 target enrollmentApril 25, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Musculoskeletal problems such as severe pain in any joints of the paretic extremity&#44
Sponsor
THE 90TH Anniversary of Chulalongkorn University Scholarship
Enrollment
20
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 25, 2019
End Date
May 31, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
THE 90TH Anniversary of Chulalongkorn University Scholarship

Eligibility Criteria

Inclusion Criteria

  • (1\)20 †80 years of age
  • (2\)Diagnosis of hemorrhagic or ischemic stroke
  • (3\)The participants can move a proximal part of the affected arm: the Manual Muscle Testing at least grade 3 of arm and less than grade 3 of hand (the participants can move upper extremity against gravity but cannot grasp something effectively).
  • (4\)Sufficient cognitive and language abilities to understand and follow instructions.
  • (5\)Adequate balance while seating at least 30 minutes.
  • (6\)Vital signs, neurological signs and medical conditions are stable.
  • (7\)The participants must leave therapy or training of hand function before the assessment for the recruitment at least 48 hours.

Exclusion Criteria

  • Musculoskeletal problems such as severe pain in any joints of the paretic extremity, instability of the wrist in the affected arm, etc.
  • Mental disorders and cognitive impairment: Thai Mental State Examination (TMSE) score ≤23
  • Contracture of shoulder joint, elbow joint, wrist joint and finger in the affected arm that hinders to use a soft robot.
  • Stroke patient who has ataxia or severe incoordination
  • The participants cannot wear a soft robot, such as allergic material case, etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials